Relationship between hepatic phenotype and changes in gene expression in cytochrome P450 reductase (POR) null mice.
Cytochrome P450 reductase is the unique electron donor for microsomal cytochrome P450s; these enzymes play a major role in the metabolism of endogenous and xenobiotic compounds. In mice with a liver-specific deletion of cytochrome P450 reductase, hepatic cytochrome P450 activity is ablated, with consequent changes in bile acid and lipid homoeostasis. In order to gain insights into the metabolic changes resulting from this phenotype, we have analysed changes in hepatic mRNA expression using microarray analysis and real-time PCR. In parallel with the perturbations in bile acid levels, changes in the expression of key enzymes involved in cholesterol and lipid homoeostasis were observed in hepatic cytochrome P450 reductase null mice. This was characterized by a reduced expression of Cyp7b1, and elevation of Cyp7a1 and Cyp8b1 expression. The levels of mRNAs for other cytochrome P450 genes, including Cyp2b10, Cyp2c29, Cyp3a11 and Cyp3a16, were increased, demonstrating that endogenous factors play a role in regulating the expression of these proteins and that the increases are due, at least in part, to altered levels of transcripts. In addition, levels of mRNAs encoding genes involved in glycolysis and lipid transport were also increased; the latter may provide an explanation for the increased hepatic lipid content observed in the hepatic null mice. Serum testosterone and oestradiol levels were lowered, accompanied by significantly decreased expression of Hsd3b2 (3beta-hydroxy-Delta5-steroid dehydrogenase-2), Hsd3b5 (3beta-hydroxy-Delta5-steroid dehydrogenase-5) and Hsd11b1 (11beta-hydroxysteroid dehydrogenase type 1), key enzymes in steroid hormone metabolism. These microarray data provide important insights into the control of metabolic pathways by the cytochrome system.
Wang
Xiu Jun
XJ
Biomedical Research Centre, Level 5, Ninewells Hospital & Medical School, Dundee DD1 9SY, UK.
Chamberlain
Mark
M
Vassieva
Olga
O
Henderson
Colin J
CJ
Wolf
C Roland
CR
D000818:Animals; D050260:Carbohydrate Metabolism; D002784:Cholesterol / Q000378:metabolism; D003599:Cytoskeleton / Q000378:metabolism; D017353:Gene Deletion; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation; D006019:Glycolysis / Q000235:genetics; D006728:Hormones / Q000378:metabolism; D007109:Immunity / Q000235:genetics; D050356:Lipid Metabolism; D008099:Liver / Q000378:metabolism*; D051379:Mice; D018345:Mice, Knockout; D009251:NADPH-Ferrihemoprotein Reductase / Q000172:deficiency* / Q000235:genetics / Q000378:metabolism*; D009369:Neoplasms / Q000235:genetics; D020411:Oligonucleotide Array Sequence Analysis; D018384:Oxidative Stress / Q000235:genetics; D010641:Phenotype; D010766:Phosphorylation; D012333:RNA, Messenger / Q000032:analysis / Q000378:metabolism; D015398:Signal Transduction / Q000235:genetics
D006728:Hormones; D012333:RNA, Messenger; D002784:Cholesterol; D009251:NADPH-Ferrihemoprotein Reductase
Mol Aspects Med. 1999 Feb-Apr;20(1-2):12-24, 25-137
10575648
Prog Lipid Res. 2004 Mar;43(2):91-104
14654089
Genes Dev. 2000 Apr 15;14(8):963-80
10783168
Mol Cell. 2000 Sep;6(3):507-15
11030331
Mol Cell. 2000 Sep;6(3):517-26
11030332
Cell. 2000 Sep 15;102(6):731-44
11030617
Annu Rev Cell Dev Biol. 2000;16:459-81
11031244
J Biol Chem. 2000 Dec 29;275(52):41087-91
11022049
Front Biosci. 2001 Mar 1;6:D388-405
11229871
J Biol Chem. 2001 Nov 23;276(47):43915-23
11522786
Biochim Biophys Acta. 2003 Feb 17;1619(3):223-34
12573481
Pharmacol Rev. 2003 Dec;55(4):649-73
14657421
J Biol Chem. 2004 Jan 23;279(4):2480-9
14583614
Diabetes. 2004 Apr;53(4):1020-9
15047617
Mol Endocrinol. 2004 Jul;18(7):1589-98
14988430
J Biol Chem. 1975 Feb 25;250(4):1571-9
234459
J Biol Chem. 1979 Sep 25;254(18):8976-81
113406
J Biol Chem. 1981 Oct 10;256(19):10066-72
6792195
J Biol Chem. 1989 May 5;264(13):7584-9
2708380
Cell. 1995 Dec 1;83(5):803-12
8521497
Eur J Biochem. 1995 Dec 1;234(2):390-6
8536680
J Biol Chem. 1996 Jul 26;271(30):18017-23
8663429
J Biol Chem. 1996 Jul 26;271(30):18024-31
8663430
J Lipid Res. 1996 Apr;37(4):693-707
8732771
EMBO J. 1996 Oct 1;15(19):5336-48
8895578
Annu Rev Pharmacol Toxicol. 1997;37:517-54
9131263
Mol Pharmacol. 1998 Apr;53(4):597-601
9547348
Cell. 1998 May 29;93(5):693-704
9630215
Biochem Biophys Res Commun. 1998 Jun 18;247(2):255-60
9642112
J Biol Chem. 1998 Dec 25;273(52):35299-306
9857071
Proc Natl Acad Sci U S A. 1999 Jan 5;96(1):266-71
9874807
Curr Opin Lipidol. 1999 Apr;10(2):143-50
10327282
Science. 1999 May 21;284(5418):1362-5
10334992
Science. 1999 May 21;284(5418):1365-8
10334993
Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11041-8
10500120
J Biol Chem. 2001 Dec 28;276(52):49066-76
11551957
Mol Pharmacol. 2002 Jan;61(1):1-6
11752199
J Cell Biochem. 2002;85(3):651-61
11968005
J Biol Chem. 2002 Jun 21;277(25):22710-7
11932260
Endocr Rev. 2002 Aug;23(4):443-63
12202460
Antioxid Redox Signal. 2002 Aug;4(4):593-602
12230871
Lancet. 2002 Oct 12;360(9340):1155-62
12387968
Biochim Biophys Acta. 2003 Feb 17;1619(3):235-8
12573482
Am J Physiol Gastrointest Liver Physiol. 2003 Mar;284(3):G349-56
12576301
Biochim Biophys Acta. 2003 Mar 17;1631(2):177-87
12633684
J Biol Chem. 2003 Apr 11;278(15):13480-6
12566435
EHP Toxicogenomics. 2003 Jan;111(1T):45-51
12735109
J Biol Chem. 2003 Jul 11;278(28):25895-901
12697746
Annu Rev Biochem. 2003;72:137-74
12543708
Arch Biochem Biophys. 2000 Feb 15;374(2):293-8
10666310